Janus Henderson Investors
Janus Henderson Investors is a global asset manager headquartered in London, United Kingdom, with a history dating back to 1934. The firm employs over 3,200 professionals worldwide, offering a broad range of investment services to institutional, retail, and high-net-worth clients. Janus Henderson is known for its research-driven approach, providing differentiated insights and disciplined investment strategies across various asset classes, including equities, fixed income, property, and alternative investments.
The firm primarily invests in Series B rounds, focusing on sectors such as Life Sciences, High Tech, and Enterprise Applications. Janus Henderson has a significant presence in the United States and the United Kingdom, with a portfolio that includes notable companies like Lyft, Workday, and Okta. The firm manages several funds, including the Janus Henderson U.S. Venture Fund and the Janus Henderson MENA Private Credit Fund IV, with assets under management totaling in the billions.
Notable investments by Janus Henderson include Lyft - ride-sharing service, Workday - enterprise cloud applications, Okta - identity management platform, IU Group - education services, and Boardriders - lifestyle apparel. These investments highlight the firm's focus on innovative and high-growth sectors, leveraging its global reach and expertise to deliver superior financial outcomes for its clients.
Japan Asia Investment Co. Ltd.
Japan Asia Investment Co., Ltd. (JAIC) was founded in 1981 by the Japan Association of Corporate Executives (Keizai Doyukai). Since its inception, JAIC has contributed to the expansion of direct investment in Asia from Japan. Meanwhile, in Japan, as a leading venture capital firm the Company has focused on cultivating, fostering and supporting venture companies and small and medium-sized enterprises, thereby contributing to the revitalization of the Japanese economy.
JAR Capital Ltd.
JAR Capital Ltd. is a private investment firm founded with a focus on offering personalized investment services. Based in London, the firm was established to provide unique investment opportunities across multiple sectors. The team comprises experienced professionals who draw upon a wide range of expertise in finance and investment management, aiming to differentiate themselves by tailoring solutions to individual client needs.
The firm invests in a diversified portfolio that spans multiple sectors without a specific focus mentioned. Typical investment sizes and specific stages of investment are not detailed in available resources. The firm has not disclosed any significant partnerships or strategic alliances.
No notable investments have been detailed in available sources, and further information pertaining to their portfolio companies is not accessible at this time.
Jardim Botanico Investimentos
Jardim Botânico Investimentos (JBI) is an independent asset management firm founded in 2003. We manage exclusively Brazilian public and private equity funds. Our investments have a long term perspective and follow a rigorous discipline through all stages. The investment team is formed by senior professionals with a long history of working together in fund management, investment analysis, M&A, market regulation and corporate governance.
Javelin Venture Partners
Javelin Venture Partners is a venture capital firm based in San Francisco, California, founded in 2008. The firm is led by a team of experienced professionals who focus on investing in software and technology companies. Javelin Venture Partners is known for its unique approach of investing in companies with 'Signal Before Traction', emphasizing early-stage investments in dynamic founders with potential for explosive growth.
The firm primarily invests in sectors such as AI, SaaS, consumer, fintech, and enterprise, with check sizes ranging from $500K to $4M. Javelin Venture Partners targets late Seed and early Series A rounds, focusing on companies in the USA, Africa, LatAm, India, Asia-Pacific, Europe, Canada, Israel, ANZ, and MENA regions. The firm is a Registered Investment Adviser (RIA) and actively seeks new investments.
Notable portfolio companies include Pair Eyewear - global eyewear, Thumbtack - home services, SmartAsset - financial advice, Higharc - homebuilding cloud, Niantic - gaming, and MasterClass - online education. These investments highlight Javelin's focus on innovative and scalable business models.
Jazz Venture Partners
JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.
We seek breakthroughs at the frontiers of technology and science, such as advances in artificial intelligence, neurobiology, augmented reality, and closed-loop human-computer systems.
Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.
JBG SMITH
JBG SMITH is a real estate investor and developer headquartered in Bethesda, Maryland. The firm focuses on placemaking in the Washington, DC metropolitan area, converting properties into vibrant, walkable neighborhoods. Their significant portfolio includes 12 million square feet of multifamily, office, and retail assets, as well as a 3.3 million square-foot development pipeline. JBG SMITH emphasizes creating value and having a positive impact in the communities they serve.
JBG SMITH is primarily focused on real estate investments within mixed-use properties in amenity-rich and metro-served submarkets around Washington, DC. They do not explicitly state investment size or stages, as their portfolio primarily consists of significant property development and management. The firm's strategic approach to creating compelling experiences through unique space design sets them apart.
Notable projects managed by JBG SMITH include developments in high-density areas such as National Landing. The firm is known for combining high-quality multifamily and commercial buildings with specialty retail and thoughtfully planned public areas. Their projects are often characterized by award-winning designs that cater to local communities and enhance urban landscapes.
JC Flowers & Co
J.C. Flowers & Co. is a private equity firm based in New York, founded in 1998 by J. Christopher Flowers. The firm is known for its expertise in the financial services sector, leveraging a team of 27 professionals with deep industry knowledge. J.C. Flowers & Co. distinguishes itself through its ability to navigate complex market dynamics and execute strategic investments globally.
The firm primarily invests in the financial services sector, including fintech and related subsectors. It focuses on buyouts, recapitalizations, and growth equity investments, with a geographical focus on the United States and the United Kingdom. J.C. Flowers & Co. manages several funds, including J.C. Flowers Fund IV and V, with assets under management totaling over $16 billion.
Notable investments by J.C. Flowers & Co. include Republic Finance - consumer finance, Monte Paschi Banque - national banks, and Strategica Group - consulting services. The firm has a track record of successful exits, including CFG Bank and Castle Trust Bank.
JD Capital
Kunwu Jiuding Investment Holding Co., Ltd. (JD Capital), headquartered in Beijing, engaged in private equity investment management and real estate development and operation business. JD Capital is listed in Shanghai Stock Exchange listed (600053.SH).
Kunwu Jiuding Investment Management Co., Ltd. is a wholly-owned subsidiary of JD Capital, a professional institution registered in Asset Management Association of China focusing on equity investment and management. The company is the co-chairman unit of equity and venture capital Professional Committee of Investment Association of China and the standing director unit of Zhongguancun Venture Capital and Equity Investment Fund Association.
Jeito Capital
Jeito Capital is a venture capital firm based in Paris, founded in 2018 by Dr Rafaèle Tordjman, who has a background as a hematologist-immunologist. The firm consists of over 30 team members who bring a combination of scientific and medical expertise alongside biotech financing experience. Jeito Capital is known for its patient-centric approach and strong emphasis on supporting European biopharma companies across various therapeutic areas.
Jeito Capital invests in clinical-stage biopharma companies, primarily within sectors such as obesity, oncology, immunology, neurology, reproductive medicine, and cardio-metabolic disease. The fund targets later-stage investments with check sizes up to an average of €150 million per company. Their geographical focus is primarily on Europe, with flexibility to operate transatlantically. The firm increased its assets under management to €1.6 billion following the closure of Jeito II. Key LPs include the European Investment Bank and other global strategic and institutional partners.
Notable companies in Jeito Capital's portfolio include EyeBio, which was sold to Merck for up to $3 billion, and another portfolio company involved in a transaction with Biogen, resulting in cumulative exit values of up to $4.8 billion. These successful exits highlight Jeito's ability to navigate the biotech landscape and deliver significant returns to its limited partners.